KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Inventory Average (2016 - 2026)

Pacira BioSciences has reported Inventory Average over the past 16 years, most recently at $151.6 million for Q1 2026.

  • For Q1 2026, Inventory Average rose 17.06% year-over-year to $151.6 million; the TTM value through Mar 2026 reached $151.6 million, up 17.06%, while the annual FY2025 figure was $139.1 million, 21.12% up from the prior year.
  • Inventory Average for Q1 2026 was $151.6 million at Pacira BioSciences, down from $155.3 million in the prior quarter.
  • Over five years, Inventory Average peaked at $155.3 million in Q4 2025 and troughed at $92.6 million in Q2 2023.
  • A 5-year average of $114.0 million and a median of $101.1 million in 2022 define the central range for Inventory Average.
  • Biggest five-year swings in Inventory Average: skyrocketed 57.27% in 2022 and later fell 9.37% in 2023.
  • Year by year, Inventory Average stood at $96.4 million in 2022, then rose by 4.15% to $100.4 million in 2023, then increased by 18.06% to $118.6 million in 2024, then skyrocketed by 30.95% to $155.3 million in 2025, then dropped by 2.35% to $151.6 million in 2026.
  • Business Quant data shows Inventory Average for PCRX at $151.6 million in Q1 2026, $155.3 million in Q4 2025, and $152.9 million in Q3 2025.